
bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern …

The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …

Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …

Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of …

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …

Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …